Pfizer SA
297.0 FTEThe score of Pfizer shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Revenue -35 % Equity +43 % Total assets +32 % Headcount (avg FTE) -12 %
Accounts of the company itself (not consolidated).
The full file covers 12 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Pfizer's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | €358.3m | ||||
| Net result | €3.67m | ||||
| Equity | €129.1m | ||||
| Cash | €23.9m | ||||
| EBITDA | €30.2m | ||||
| Total assets | €377.4m |
Filed annual accounts
- Year ended 30 Nov 2025filed on 02 Jun 2026
- Year ended 30 Nov 2024filed on 23 May 2025
- Year ended 30 Nov 2023filed on 21 May 2024
- Year ended 30 Nov 2022filed on 23 May 2023
- Year ended 30 Nov 2021filed on 01 Jun 2022
Pfizer's financial analysis
- Solvency34.2%sector median: 41.4%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Pfizer
Pfizer's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0401.994.823
- VAT number
- BE0401994823
- Peppol
- Registered · 0208:0401994823 · as of 03 Nov 2026
- Legal form
- SA
- Incorporated
- 01 Feb 1954
- Registered office
- 1050 Ixelles
- Size
- Large · 297.0 FTE
- Latest accounts
- 2025 · filed on 02 Jun 2026
- Activity
- Manufacture of medicaments (NACE 21201)
Pfizer (SA) has been based in Ixelles since 1954, active in: manufacture of medicaments. For 2025, it reports revenue of €358.3m, a net profit of €3.67m and equity of €129.1m. With 297.0 full-time equivalents, it is a large enterprise by headcount. Its solvency stands at 34.2%, below the median of its sector (41.4%).
Companies similar to Pfizer
Companies in the same business, of comparable size and area, outside its group.
- Organon Heist Manufacture of pharmaceutical preparations Heist-op-den-Berg · balance sheet €349.6m
- PHOENIX Pharma Belgium Manufacture of pharmaceutical preparations Woluwe-Saint-Lambert · balance sheet €235.4m
- Ipsen Manufacture of pharmaceutical preparations Brussels · balance sheet €134.4m
- Novartis Manufacturing Manufacture of pharmaceutical preparations Puurs-Sint-Amands · balance sheet €285.2m
- Roche Manufacture of pharmaceutical preparations Anderlecht · balance sheet €164.7m
- Laboratoires S.M.B. Manufacture of pharmaceutical preparations Molenbeek-Saint-Jean · balance sheet €261.5m
- SERB Wholesale of pharmaceutical and medical goods Ixelles · balance sheet €159.3m
- Ajinomoto Omnichem Manufacture of basic pharmaceutical products Wetteren · balance sheet €476.3m
Frequently asked questions about Pfizer
What is the revenue of Pfizer?
According to the 2025 annual accounts filed with the NBB, the revenue of Pfizer amounts to 358,343,084 €.
What is the VAT number of Pfizer?
In Belgium, the VAT number is the company number prefixed with BE: BE0401994823 for Pfizer, if the company is VAT-registered. Its company number (CBE) is 0401.994.823.
Where is the registered office of Pfizer?
According to the CBE register, the registered office of Pfizer is in 1050 Ixelles.
What is the equity of Pfizer?
At the close of the 2025 financial year, the equity of Pfizer amounts to 129,067,951 €, a solvency of 34.2% of total assets.
How many people work at Pfizer?
297.0 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Pfizer?
The register lists 5 active mandates at Pfizer. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Pfizer
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →